Mattias Wieloch (@dr_wieloch) 's Twitter Profile
Mattias Wieloch

@dr_wieloch

Father, Husband, Cardiologist, Healtcare&Global pharma leader. Passion4 science and benefit of patients. My tweets are my own. @lunduniversity @sanofi

ID: 1431174565770760205

calendar_today27-08-2021 08:39:56

167 Tweet

46 Takipçi

71 Takip Edilen

John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

Gregg Fonarow MD -- we are going to have to change systems to accomplish what you've been advocating for. 4 Visits with cardiologists in the 6 weeks after HF discharge --> outcomes are better. #aha22

Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

#SimPub with #AHA22 from #DELIVER in European Society of Cardiology Journals #EJHF Dapa highly effective in reducing clinical events, even among those already treated with #MRA or #ARNI. SGLT2i may be added to other treatments recommended in recent guidelines for #HFmrEF/#HFpEF. onlinelibrary.wiley.com/doi/full/10.10…

#SimPub with #AHA22 from #DELIVER in <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #EJHF

Dapa highly effective in reducing clinical events, even among those already treated with #MRA or #ARNI. SGLT2i may be added to other treatments recommended in recent guidelines for #HFmrEF/#HFpEF.

onlinelibrary.wiley.com/doi/full/10.10…
Mattias Wieloch (@dr_wieloch) 's Twitter Profile Photo

HbA1c 6.44%= no diabetes diagnose, while 6.50% ➡️ diagnose… Important finding, and high-lights problem with arbitrary cut-offs for disease yes/no in studies

Jeffrey M Vinocur (@jeffrey_vinocur) 's Twitter Profile Photo

Edmond Cronin I can’t understand why we would use short-acting metoprolol BID for any indication. Even at TID the pharmacokinetics are not very appealing. pubmed.ncbi.nlm.nih.gov/11782853/ @JJheart_doc

<a href="/dredcronin/">Edmond Cronin</a> I can’t understand why we would use short-acting metoprolol BID for any indication. Even at TID the pharmacokinetics are not very appealing. 

pubmed.ncbi.nlm.nih.gov/11782853/ @JJheart_doc
Ilya Shadrin, MD/PhD (@ishadrinmdphd) 's Twitter Profile Photo

Fantastic presentation by Jonathan Piccini, MD, MHS discussing 4 pillars of #afib management, including importance of rhythm control. STALL- HF showing an impressively high prevalence (65%) of HFpEF in afib patients. Ongoing CHANGE-AF trial assessing dronaderone in new afib. #BackToHeart22

Fantastic presentation by <a href="/JonPicciniSr/">Jonathan Piccini, MD, MHS</a> discussing 4 pillars of #afib management, including importance of rhythm control. STALL- HF showing an impressively high prevalence (65%) of HFpEF in afib patients. Ongoing CHANGE-AF trial assessing dronaderone in new afib. #BackToHeart22
StopAfib.org (@stopafib) 's Twitter Profile Photo

Atrial fibrillation (#afib) patient advocacy training program. US candidates only. Please share, Jonathan Piccini, MD, MHS @debbemccall #ePeeps #CardioTwitter stopafib.org/afib-news-even…

Ankeet S. Bhatt, MD, MBA (@ankeetbhatt) 's Twitter Profile Photo

Now out in JACC Journals jacc.org/doi/epdf/10.10…; new data on health status in #DELIVER! Dapa improves #KCCQ across all clinically relevant domains. A pleasure to write this with scottdavidsolomon Mikhail Kosiborod Muthu Vaduganathan and team! See delivertrial.org for more!

Now out in <a href="/JACCJournals/">JACC Journals</a> jacc.org/doi/epdf/10.10…; new data on health status in #DELIVER! Dapa improves #KCCQ across all clinically relevant domains. A pleasure to write this with <a href="/scottdsolomon/">scottdavidsolomon</a> <a href="/MkosiborodMD/">Mikhail Kosiborod</a> <a href="/mvaduganathan/">Muthu Vaduganathan</a> and team! See delivertrial.org for more!
AFNET (@afnet_ev) 's Twitter Profile Photo

#EastTrial changing the perspective on #EarlyRhythmControlTherapy in patients with early #Afib and #comorbidities and could influence guidelines for clinical practice. Find a summary of the main findings and several subgroup analysis on bit.ly/3FX1XIV #afnet_ev

#EastTrial changing the perspective on #EarlyRhythmControlTherapy in patients with early #Afib and #comorbidities and could influence guidelines for clinical practice. Find a summary of the main findings and several subgroup analysis on bit.ly/3FX1XIV  #afnet_ev
Dr. Helmut Pürerfellner (@purerfellner) 's Twitter Profile Photo

20 years of EHRA and the beat goes on: In the context of our anniversary, I would like to recognize some #EHRA colleagues: Jose L. Merino, EHRA president. U better follow him: Jose Luis Merino #cardiology #electrophysiology #EHRA2023 #EHRA_ESC #youngep #epeeps

20 years of EHRA and the beat goes on: In the context of our anniversary, I would like to recognize some #EHRA colleagues: Jose L. Merino, EHRA president. U better follow him: <a href="/joselmerino/">Jose Luis Merino</a> 
#cardiology #electrophysiology #EHRA2023 #EHRA_ESC #youngep #epeeps
AFNET (@afnet_ev) 's Twitter Profile Photo

Gut #microbiome derived metabolites in #AFib Are we dealing with #RiskMarkers or modifiable #RiskFactors? Dominik Linz CARIM UKE Hamburg #Vorhofflimmern #Cardiotwitter #health #stroke #heart #symptoms #strokes #signagainststroke bit.ly/3QbAE0I

Gut #microbiome derived metabolites in #AFib
Are we dealing with #RiskMarkers or modifiable #RiskFactors? 
<a href="/Dominik_Linz/">Dominik Linz</a> <a href="/CARIMMaastricht/">CARIM</a> <a href="/UKEHamburg/">UKE Hamburg</a> 
#Vorhofflimmern  
#Cardiotwitter 
#health
#stroke
#heart
#symptoms
#strokes
#signagainststroke
bit.ly/3QbAE0I
Sanjiv Narayan (@s_narayanmd) 's Twitter Profile Photo

#EPeeps Recurrent #afib but durable PVI: PARTY-PVI (N=367): No redo strategy alone or combined was superior👇 Raphael Martins @LaurentMacle Either(a) nothing will work☹️ (b) find best target per pt - not population🤔 or.. ahajournals.org/doi/abs/10.116… Elad Anter William H. Sauer, MD Vivek Y. Reddy

Nassir Marrouche (@nmarrouche) 's Twitter Profile Photo

AI analysis finds younger AFib patients benefit from MRI-guided ablation treatments | Tulane News ⁦Tulane Medicine⁩ ⁦TulaneTRIAD⁩ ⁦Chan Ho Lim⁩ ⁦@HadiiYounes⁩ ⁦Ala' Assaf⁩ ⁦Nadia Chamoun⁩ news.tulane.edu/pr/ai-analysis…